ILC Dover Defines the Future of Sterile Manufacturing with the soloPURE(TM) Flexible Aseptic Isolator

ILC Dover, Inc.

AsiaNet 88970

 

NEWARK, Del., April 13, 2021 /PRNewswire=KYODO JBN/ --

 

ILC Dover LP ("ILC Dover" or the "Company"), specializing in the innovative

design and production of single-use flexible solutions for global

pharmaceutical and biopharmaceutical processing, today introduced the

soloPURE(TM) flexible aseptic isolator, a cost-effective, closed-barrier system

for sterile manufacturing. With a fully disposable, single-use chamber and a

CAPEX-efficient compact design, soloPURE(TM) represents the future of sterile

manufacturing.

 

Photo - https://mma.prnewswire.com/media/1485718/ILC_Dover_LP_soloPURE.jpg

 

soloPURE(TM) provides a closed, Grade-A, aseptic environment for fill finish

activities requiring positive and negative pressures, giving organizations with

facility restraints or expensive closed-barrier systems a better way to handle

sterile potent powders, including products previously thought to be "out of

reach" in conventional barrier systems. This economical flexible isolator

delivers performance equivalent to full hard-walled aseptic isolation systems

through bolt-on modules for lyophilization that deliver more capabilities

without the added expense. Beyond cost savings, soloPURE(TM) maximizes

productivity with a fully disposable chamber, maximizes cleanroom efficiency

through a smaller footprint, enhances operator access with double-sided entry,

and mitigates risk with integrity testing throughout its lifecycle.

 

"ILC Dover is proud to introduce soloPURE(TM) to the biopharmaceutical market

and provide significant time and cost savings to processors through effective

single-use solutions," said David Radspinner, President of PharmBio at ILC

Dover. "soloPURE(TM) combines Solo Containment's rich history in single-use

isolators and ILC Dover's expertise in flexible powder handling solutions to

deliver an efficient, economical, and safe isolator that drastically improves

workflow and output for sterile manufacturing."

 

"soloPURE(TM) demonstrates both the processing power and sensibility behind

single-use solutions, especially for sterile or aseptic processes," said Martyn

Ryder, Business and Product Development Manager at ILC Dover. "The single-use,

disposable chamber alone allows for rapid campaign changeover, while its

double-sided entry increases productivity. While single-use solutions have

eluded aseptic processes for decades, soloPURE(TM) is here to represent the

future of sterile manufacturing."

 

soloPURE(TM) is available with the capability to sterilize in-place with VHP or

operate with a single-use, disposable gamma-irradiated chamber. It can be

ordered as a turnkey solution with fast delivery. The launch of soloPURE(TM)

supplements ILC Dover's growing portfolio of single-use solutions for sterile

processes and powder transport and hydration, including EZ BioPac(R),

DoverPac(R), and ArmorFlex(R) Films.

 

SOURCE: ILC Dover, Inc.

  

 

本プレスリリースは発表元が入力した原稿をそのまま掲載しております。また、プレスリリースへのお問い合わせは発表元に直接お願いいたします。

このプレスリリースには、報道機関向けの情報があります。

プレス会員登録を行うと、広報担当者の連絡先や、イベント・記者会見の情報など、報道機関だけに公開する情報が閲覧できるようになります。

プレスリリース受信に関するご案内

SNSでも最新のプレスリリース情報をいち早く配信中